These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 30139273)
1. Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: A narrative review. Lauritsen CG; Silberstein SD Cephalalgia; 2019 May; 39(6):750-760. PubMed ID: 30139273 [TBL] [Abstract][Full Text] [Related]
2. Effects of external trigeminal nerve stimulation (eTNS) on laser evoked cortical potentials (LEP): A pilot study in migraine patients and controls. Vecchio E; Gentile E; Franco G; Ricci K; de Tommaso M Cephalalgia; 2018 Jun; 38(7):1245-1256. PubMed ID: 28856913 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of real versus sham external Trigeminal Nerve Stimulation (eTNS) in youth with Attention-Deficit/Hyperactivity Disorder (ADHD) over 4 weeks: a protocol for a multi-centre, double-blind, randomized, parallel-group, phase IIb study (ATTENS). Rubia K; Johansson L; Carter B; Stringer D; Santosh P; Mehta MA; Conti AA; Bozhilova N; Eraydin IE; Cortese S BMC Psychiatry; 2024 Apr; 24(1):326. PubMed ID: 38689273 [TBL] [Abstract][Full Text] [Related]
10. External trigeminal neurostimulation in patients with chronic migraine. Trimboli M; Marsico O; Troisi L; Fasano F Pain Manag; 2023 Mar; 13(3):185-192. PubMed ID: 37010047 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive neuromodulation in migraine and cluster headache. Starling A Curr Opin Neurol; 2018 Jun; 31(3):268-273. PubMed ID: 29601305 [TBL] [Abstract][Full Text] [Related]
12. Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine. Magis D; D'Ostilio K; Thibaut A; De Pasqua V; Gerard P; Hustinx R; Laureys S; Schoenen J Cephalalgia; 2017 Aug; 37(9):881-891. PubMed ID: 27342225 [TBL] [Abstract][Full Text] [Related]
13. Non-invasive transcutaneous Supraorbital Neurostimulation (tSNS) using Cefaly Przeklasa-Muszyńska A; Skrzypiec K; Kocot-Kępska M; Dobrogowski J; Wiatr M; Mika J Neurol Neurochir Pol; 2017; 51(2):127-134. PubMed ID: 28159327 [TBL] [Abstract][Full Text] [Related]
14. [Neurostimulation of the supraorbital nerve with the Cefaly device - a new method for the treatment of migraine]. Tabeeva GR Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3):133-140. PubMed ID: 31089108 [TBL] [Abstract][Full Text] [Related]
16. Peripheral Neuromodulation for the Management of Headache. Urits I; Schwartz R; Smoots D; Koop L; Veeravelli S; Orhurhu V; Cornett EM; Manchikanti L; Kaye AD; Imani F; Varrassi G; Viswanath O Anesth Pain Med; 2020 Dec; 10(6):e110515. PubMed ID: 34150578 [TBL] [Abstract][Full Text] [Related]
17. Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study. Vikelis M; Dermitzakis EV; Spingos KC; Vasiliadis GG; Vlachos GS; Kararizou E BMC Neurol; 2017 May; 17(1):97. PubMed ID: 28521762 [TBL] [Abstract][Full Text] [Related]
18. The safety and preventive effects of a supraorbital transcutaneous stimulator in Japanese migraine patients. Danno D; Iigaya M; Imai N; Igarashi H; Takeshima T Sci Rep; 2019 Jul; 9(1):9900. PubMed ID: 31289281 [TBL] [Abstract][Full Text] [Related]
20. A device review of Relivion®: an external combined occipital and trigeminal neurostimulation (eCOT-NS) system for self-administered treatment of migraine and major depressive disorder. Daniel O; Sharon R; Tepper SJ Expert Rev Med Devices; 2021 Apr; 18(4):333-342. PubMed ID: 33787443 [No Abstract] [Full Text] [Related] [Next] [New Search]